← Leaderboards
Tamara G Fong
Beth Israel Deaconess Medical Center
$1,216,172
Attributed
$1,216,172
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $252.8K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,216,172 · 4
By mechanism
K23$630,315 · 1
R21$470,800 · 1
F32$114,072 · 1
M01$985 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Edward R Marcantonio$19,902,198
- Daniel Z. Press$4,768,036
- Weiqun Yu$4,262,803
- Jun Lu$8,136,814
Others in their field
Top investigators on “Cognition”
- David R. Weir · University Of Michigan At Ann Arbor$380,402,429
- Paul S. Aisen · Cognition Therapeutics, Inc.$185,453,129
- Randall J Bateman · Washington University$179,917,643
- Reisa A. Sperling · Banner Health$160,454,465
- Michael W Weiner · Northern California Institute Res &Educ$153,571,751
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,618,221
Research focus
CognitionDementiaFunctional DisorderNeuronsDeliriumCognitive FunctionCognitiveBloodAgingLeadPerfusionPerformanceSeveritiesInnovationMagnetic Resonance ImagingCholinergicIn VivoCholinergic AgentsAffectClinical ResearchEffective TherapyDouble-Blind MethodElectromagneticsCholinesterase Inhibitors
Grant awards (10)
Blood-based biomarkers of neuronal injury and Alzheimer's disease: predictors of delirium and long-term cognitive decline, and potential shared pathophysiology$252,791
R21 · FY2018 · AG · contact PI
Blood-based biomarkers of neuronal injury and Alzheimer's disease: predictors of delirium and long-term cognitive decline, and potential shared pathophysiology$218,009
R21 · FY2017 · AG · contact PI
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusio$126,063
K23 · FY2012 · AG · contact PI
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusio$126,063
K23 · FY2011 · AG · contact PI
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusio$126,063
K23 · FY2010 · AG · contact PI
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusio$126,063
K23 · FY2009 · AG · contact PI
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusio$126,063
K23 · FY2008 · AG · contact PI
CHOLINERGIC AND COGNITIVE FUNCTION USING PHARMACOLOGIC ASL-PERFUSION MRI$985
M01 · FY2008 · RR · contact PI
Perfusion MRI After Donepezil in Lewy Body Dementia$57,536
F32 · FY2005 · NS
Perfusion MRI After Rivastigmine in Lewy Body Dementia$56,536
F32 · FY2004 · NS